Pulmonary arterial hypertension in a patient treated with dasatinib: a case report

BACKGROUND: There have been several reports on dasatinib-induced reversible pulmonary hypertension. This is the first reported case in Latvia; the patient did not discontinue the drug after the first adverse effects in the form of pleural effusions, which we speculate led only to partial reversion o...

Descripción completa

Detalles Bibliográficos
Autores principales: Skride, Andris, Sablinskis, Matiss, Sablinskis, Kristaps, Lesina, Krista, Lejnieks, Aivars, Lejniece, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747081/
https://www.ncbi.nlm.nih.gov/pubmed/29287600
http://dx.doi.org/10.1186/s13256-017-1515-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747081/
https://www.ncbi.nlm.nih.gov/pubmed/29287600
http://dx.doi.org/10.1186/s13256-017-1515-9

Ejemplares similares